World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

NexPoint Capital, Inc. Announces Tender Offer for Common Stock

Cision PR Newswire by Cision PR Newswire
December 19, 2025
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

DALLAS, Dec. 19, 2025 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced the expiration and final results for its tender offer (the “Tender Offer”) for up to 1.5% of its outstanding common stock (“Shares”) at a price of $4.75 per Share as of December 16, 2025, plus any unpaid dividends accrued through the expiration date of the Tender Offer. The Fund’s Tender Offer expired on December 16, 2025, at 4:00 p.m. Eastern Time. 127,320.8299 shares of the Company were tendered for repurchase in the Tender Offer.


NexPoint Capital Logo

Any questions regarding the Tender Offer can be directed to the Company’s Tender Agent, LODAS Transfer, LLC, at (833) 586-1960.  The Company’s current offering price for its Shares, as well as other information, including information about management and the healthcare-focused investment strategy, are available at nexpoint.com. The information on or accessible through nexpoint.com is not incorporated by reference herein.

About NexPoint Capital, Inc.

NexPoint Capital, Inc. is a non-traded, publicly registered business development company sponsored and managed by NexPoint Advisors, L.P.

About NexPoint Advisors, L.P.

NexPoint Advisors, L.P. (“NexPoint Advisors”) is an SEC-registered adviser on the NexPoint alternative investment platform (“NexPoint”). NexPoint Advisors serves as the adviser to a suite of funds and investment vehicles, including a closed-end fund, interval fund, business development company (“BDC”), and various real estate vehicles. For more information visit www.nexpoint.com. 

Except for the historical information and discussions contained herein, statements contained in this news release constitute forward-looking statements. These statements may involve a number of risks, uncertainties, and other factors that could cause actual results to differ materially, including the performance of financial markets, the investment performance of NexPoint Advisors’ sponsored investment products, general economic conditions, future acquisitions, competitive conditions, and government regulations, including changes in tax laws. Readers should carefully consider such factors. Further, such forward-looking statements speak only on the date at which such statements are made. NexPoint Advisors undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statement.

This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy, or investment product. Neither the Company, nor the Company’s Board of Directors, nor NexPoint Advisors makes any recommendation as to whether to tender or not to tender any Shares in the Tender Offer. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission.

Contact Information for Tender Offer:

Financial Advisors: (855) 498-1580

Shareholders: (833) 586-1960

Media Contact: Comms@nexpoint.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nexpoint-capital-inc-announces-tender-offer-for-common-stock-302647221.html

SOURCE NexPoint Capital, Inc.

Cision PR Newswire

Cision PR Newswire

Related Posts

Aurra Markets Crowned ‘Best Emerging Broker’ at Forex Expo Dubai 2026

September 28, 2026

Yili Shares China’s Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference

September 28, 2026

Ancient Wushu Meets AIGC: How Cangzhou Is Reimagining Its Cultural Story

September 28, 2026

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

September 28, 2026

Poseidon Capital Partners appoints Premialab to strengthen QIS-driven portfolio construction

September 28, 2026

Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC

September 28, 2026

Popular News

  • Aurra Markets Crowned ‘Best Emerging Broker’ at Forex Expo Dubai 2026

    0 shares
    Share 0 Tweet 0
  • Yili Shares China’s Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference

    0 shares
    Share 0 Tweet 0
  • Ancient Wushu Meets AIGC: How Cangzhou Is Reimagining Its Cultural Story

    0 shares
    Share 0 Tweet 0
  • Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

    0 shares
    Share 0 Tweet 0
  • Poseidon Capital Partners appoints Premialab to strengthen QIS-driven portfolio construction

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler